Federico Innocenti

Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer.

A. Venook, J. Millstein, F. Ou, 2024, European Journal of Cancer.

Germline cis variant determines epigenetic regulation of the anti-cancer drug metabolism gene dihydropyrimidine dehydrogenase (DPYD).

A. Etheridge, S. Offer, R. Schmidt, 2024, eLife.

Germline cis variant determines epigenetic regulation of the anti-cancer drug metabolism gene dihydropyrimidine dehydrogenase (DPYD)

Zhiquan Wang, A. Etheridge, S. Offer, 2023, bioRxiv.

Common variation in a long non-coding RNA gene modulates variation of circulating TGF-β2 levels in metastatic colorectal cancer patients (Alliance)

K. Owzar, M. Ratain, A. Sibley, 2024, BMC genomics.

Gene expression biomarkers differentiate overall survival of colorectal cancer upon targeted therapies

G. Pillonetto, S. Kopetz, A. Yazdani, 2024, Research square.

CCR5 and CCL5 gene expression in colorectal cancer: comprehensive profiling and clinical value

Taline Khoukaz, A. Venook, J. Millstein, 2024, Journal for immunotherapy of cancer.